Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1981 Jun;56(6):455–459. doi: 10.1136/adc.56.6.455

Variability of airways hyper-reactivity and allergy in cystic fibrosis.

F J Holzer, A Olinsky, P D Phelan
PMCID: PMC1627471  PMID: 7259276

Abstract

The importance of bronchial hyper-reactivity and allergy, and treatment with bronchodilators and corticosteroids, in the management of patients with cystic fibrosis is poorly understood. Three tests generally regarded as useful in the diagnosis of asthma were evaluated in 25 children with cystic fibrosis. The constancy of a child's response was assessed by histamine bronchial provocation, exercise challenge, and tests of skin allergy during a 6-month period. Although a positive response to these tests was related to impaired pulmonary function, 44% of children had variable responses to histamine, 56% to exercise, and 24% to skin tests which were unrelated to exacerbations of chest infection or to changes in pulmonary function. These results show the complex nature of airways hyper-reactivity and allergy in cystic fibrosis, and suggest that 'anti-asthma' therapy is not justified solely on the basis of one positive response to these tests.

Full text

PDF
455

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan J. D., Moss A. D., Wallwork J. C., McFarlane H. Immediate hypersensitivity in patients with cystic fibrosis. Clin Allergy. 1975 Sep;5(3):255–261. doi: 10.1111/j.1365-2222.1975.tb01860.x. [DOI] [PubMed] [Google Scholar]
  2. COOK C. D., HAMANN J. F. Relation of lung volumes to height in healthy persons between the ages of 5 and 38 years. J Pediatr. 1961 Nov;59:710–714. doi: 10.1016/s0022-3476(61)80007-3. [DOI] [PubMed] [Google Scholar]
  3. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  4. Counahan R., Mearns M. B. Prevalence of atopy and exercise-induced bronchial lability in relatives of patients with cystic fibrosis. Arch Dis Child. 1975 Jun;50(6):477–481. doi: 10.1136/adc.50.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Day G., Mearns M. B. Bronchial lability in cystic fibrosis. Arch Dis Child. 1973 May;48(5):355–359. doi: 10.1136/adc.48.5.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GIBSON L. E., COOKE R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed] [Google Scholar]
  7. Haluszka J., Sciślicki A. Bronchial lability in children suffering from some diseases of the bronchi. Respiration. 1975;32(3):217–226. doi: 10.1159/000193651. [DOI] [PubMed] [Google Scholar]
  8. Kattan M., Keens T. G., Mellis C. M., Levison H. The response to exercise in normal and asthmatic children. J Pediatr. 1978 May;92(5):718–721. doi: 10.1016/s0022-3476(78)80135-8. [DOI] [PubMed] [Google Scholar]
  9. Knudson R. J., Mead J., Knudson D. E. Contribution of airway collapse to supramaximal expiratory flows. J Appl Physiol. 1974 Jun;36(6):653–667. doi: 10.1152/jappl.1974.36.6.653. [DOI] [PubMed] [Google Scholar]
  10. Landau L. I., Phelan P. D. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis. J Pediatr. 1973 May;82(5):863–868. doi: 10.1016/s0022-3476(73)80085-x. [DOI] [PubMed] [Google Scholar]
  11. Landau L. I., Taussig L. M., Macklem P. T., Beaudry P. H. Contribution of inhomogeneity of lung units to the maximal expiratory flow-volume curve in children with asthma and cystic fibrosis. Am Rev Respir Dis. 1975 Jun;111(6):725–731. doi: 10.1164/arrd.1975.111.6.725. [DOI] [PubMed] [Google Scholar]
  12. MURRAY A. B., COOK C. D. Measurement of peak expiratory flow rates in 220 normal children from 4.5 to 18.5 years of age. J Pediatr. 1963 Feb;62:186–189. doi: 10.1016/s0022-3476(63)80390-x. [DOI] [PubMed] [Google Scholar]
  13. McNichol K. N., Williams H. E. Spectrum of asthma in children. II. Allergic components. Br Med J. 1973 Oct 6;4(5883):12–16. doi: 10.1136/bmj.4.5883.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mellis C. M., Levison H. Bronchial reactivity in cystic fibrosis. Pediatrics. 1978 Mar;61(3):446–450. [PubMed] [Google Scholar]
  16. Skorecki K., Levison H., Crozier D. N. Bronchial lability in cystic fibrosis. Acta Paediatr Scand. 1976 Jan;65(1):39–44. doi: 10.1111/j.1651-2227.1976.tb04405.x. [DOI] [PubMed] [Google Scholar]
  17. Warner J. O., Norman A. P., Soothill J. F. Cystic fibrosis heterozygosity in the pathogenesis of allergy. Lancet. 1976 May 8;1(7967):990–991. doi: 10.1016/s0140-6736(76)91862-6. [DOI] [PubMed] [Google Scholar]
  18. Warner J. O., Taylor B. W., Norman A. P., Soothill J. F. Association of cystic fibrosis with allergy. Arch Dis Child. 1976 Jul;51(7):507–511. doi: 10.1136/adc.51.7.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Warner J. O. The variability of skin test hypersensitivity reactions in cystic fibrosis and asthma. Clin Allergy. 1977 Jul;7(4):385–389. doi: 10.1111/j.1365-2222.1977.tb01467.x. [DOI] [PubMed] [Google Scholar]
  20. Williams H., McNicol K. N. Prevalence, natural history, and relationship of wheezy bronchitis and asthma in children. An epidemiological study. Br Med J. 1969 Nov 8;4(5679):321–325. doi: 10.1136/bmj.4.5679.321. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES